Feb 17, 2023
SWOG recently reported notable results from S1416 in breast cancer and S1815 in biliary tract cancers
Feb 17, 2023
Feb 10, 2023
Feb 3, 2023
Jan 30, 2023
S1416 trial results show PARP inhibitor benefit in "BRCA-like" triple-negative breast cancer
Jan 27, 2023
Jan 20, 2023
Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some